Key facts
- Invesco Ltd. filed SCHEDULE 13G for Collegium Pharmaceutical Inc Common Stock (COLL).
- Disclosed ownership: 5%.
- Date of event: 31 Mar 2026.
Invesco Ltd. - 31 Mar 2026 SCHEDULE 13G Report for Collegium Pharmaceutical Inc Common Stock (COLL)
- Filing Manager
- Invesco Ltd.
- Reporting Manager
- Invesco Ltd.
- Symbol
- COLL
- Shares outstanding
- 31,838,180 shares
- Disclosed Ownership
- 1,591,909 shares
- Ownership
- 5%
- Form type
- SCHEDULE 13G
- Filing time
- 08 May 2026, 10:17:06 UTC
- Date of event
- 31 Mar 2026
- Previous filing
- 07 Aug 2025
- SEC
- View on sec.gov
Key filing fact
Invesco Ltd. disclosed 5% ownership in Collegium Pharmaceutical Inc Common Stock (COLL) on 31 Mar 2026.
Change
- Previous schedule filing date: 07 Aug 2025.
- Current filing was accepted on 08 May 2026, 10:17.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (1)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Invesco Ltd. | 5% | 1,591,909 | 1,490,397 | 0 | Robert R. Leveille | Global Head of Compliance |
CIK / CUSIP context first